NEW YORK, NY / ACCESSWIRE / June 15, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
GSX Techedu Inc. (NYSE:GSX)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/gsx-techedu-inc-loss-submission-form?prid=7348&wire=1
Lead Plaintiff Deadline: June 16, 2020
Class Period: June 6, 2019 - April 13, 2020
Allegations against GSX include that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Groupon, Inc. (NASDAQ:GRPN)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/groupon-inc-loss-submission-form?prid=7348&wire=1
Lead Plaintiff Deadline: June 29, 2020
Class Period: November 4, 2019 - February 18, 2020
Allegations against GRPN include that: (1) the Company was experiencing fewer customer engagements in its Goods category; (2) Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/sorrento-therapeutics-inc-loss-submission-form?prid=7348&wire=1
Lead Plaintiff Deadline: July 27, 2020
Class Period: May 15, 2020 - May 22, 2020
Allegations against SRNE include that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com:
https://www.accesswire.com/593899/SHAREHOLDER-ALERT-GSX-GRPN-SRNE-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines
